NPI Details
Phillip Andrew Musikanth, MD is an internal medicine in Los Angeles, CA. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Phillip Andrew Musikanth, MD NPI is 1760495741. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
5901 W OLYMPIC BLVD
STE 401
LOS ANGELES, CA
ZIP 90036-667
Phone: (323) 954-1073
Fax: (323) 954-1081
The NPI 1760495741 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Phosphate level (HCPCS:84100)
- Testosterone (hormone) level, free (HCPCS:84402)
- Testosterone (hormone) level, total (HCPCS:84403)
- Detection test by nucleic acid for hiv-1 virus, quantification (HCPCS:87536)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
- Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Vitamin d-3 level (HCPCS:82306)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Liver function blood test panel (HCPCS:80076)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Screening examination of specimen cells, preparation, screening and interpretation (HCPCS:88161)
- Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
- Magnesium level (HCPCS:83735)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Folic acid level, serum (HCPCS:82746)
- Uric acid level, blood (HCPCS:84550)
- Measurement of total estradiol (hormone) (HCPCS:82670)
- Gonadotropin, follicle stimulating (reproductive hormone) level (HCPCS:83001)
- Gonadotropin, luteinizing (reproductive hormone) level (HCPCS:83002)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Sex hormone binding globulin (protein) level (HCPCS:84270)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Thyroid hormone, t3 measurement, free (HCPCS:84481)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Hemoglobin a1c level (HCPCS:83036)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
The enumeration date for this NPI number is 8/14/2006 and was last updated on 4/16/2014.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 174400000X | Specialist | | A50223 | CALIFORNIA | No |
| 2 | 207R00000X | Internal Medicine | | A50223 | CALIFORNIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 00A502230 | MEDICAID | CALIFORNIA | |
| 2 | F60892 | MEDICARE UPIN | CALIFORNIA | |
| 3 | S60892 | MEDICARE UPIN | | |
| 4 | WA50223G, WA50223H | MEDICARE ID-TYPE UNSPECIFIED | CALIFORNIA | |
